In the case of T-47D, this breast cancer cell type represents a particular case of a patient expressing 17β-HSD1 almost exclusively with a very low expression of aromatase, and who could be treated following a 17β-HSD1 inhibitor monotherapy. The gene discussed is CYP19A1; the disease is breast carcinoma.